Literature DB >> 14675577

Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study).

Jens Friberg1, Henrik Scharling, Niels Gadsbøll, Gorm B Jensen.   

Abstract

Atrial fibrillation (AF) is the most frequently encountered cardiac arrhythmia. It is a risk factor for stroke and premature death. We studied the temporal changes in the prevalence of AF from 1976 to 1994 in a random population aged 50 to 89 years. The prevalence of AF, diagnosed from electrocardiograms (ECGs), was determined in 8,606 patients examined in 1976 to 1978, in 8,943 patients examined in 1981 to 1983, and in 6,733 subjects examined in 1991 to 1994. Changes in prevalence of AF were estimated by logistic regression analysis. In men, the age-standardized prevalence of AF increased from 1.4% in 1976 to 1978 (odds ratio [OR] 1.0, reference) to 1.9% in 1981 to 1983 (OR 1.6, 95% confidence interval [CI] 1.1 to 2.1), and to 3.3% in 1991 to 1994 (OR 2.3, 95% CI 1.6 to 3.4, p<0.001, adjusted for age). In women, the prevalence of AF decreased from 1.5% in 1976 to 1978 (OR 1.0, reference) to 1.0% in 1981 to 1983 (OR 0.7, 95% CI 0.5 to 1.0), and to 1.1% in 1991 to 1994 (OR 0.7, 95% CI 0.5 to 1.0), although the overall decrease was not significant (p=0.11, adjusted for age). After adjusting for changes in comorbidity, body weight, and height, the increase in the prevalence of AF in men from 1976 to 1978 and from 1991 to 1994 remained significant (OR 1.9, 95% CI 1.3 to 2.8, p=0.002). Although unchanged in women, the prevalence of AF in men more than doubled from the 1970s to the 1990s. The factors responsible for this gender-specific increase in the prevalence of this common arrhythmia have yet to be identified.

Entities:  

Mesh:

Year:  2003        PMID: 14675577     DOI: 10.1016/j.amjcard.2003.08.050

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

Review 1.  Prevention of heart failure in the elderly: when, where and how to begin?

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: markers of myocardial damage, inflammation, and thrombogenesis.

Authors:  Bor Antolič; Andrej Pernat; Marta Cvijić; David Žižek; Matevž Jan; Matjaž Šinkovec
Journal:  Wien Klin Wochenschr       Date:  2016-06-06       Impact factor: 1.704

3.  A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.

Authors:  Elisabetta Bucci; Marco Testa; Loretta Licchelli; Alessandra Frattari; Nadia Attalla El Halabieh; Erica Gabriele; Giulia Pignatelli; Tiziana De Santis; Laura Fionda; Fiammetta Vanoli; Stefania Morino; Matteo Garibaldi; Antonella Di Pasquale; Nicola Vanacore; Annalisa Botta; Giovanni Antonini
Journal:  J Neurol       Date:  2018-02-10       Impact factor: 4.849

4.  Holter monitoring to detect silent atrial fibrillation in high-risk subjects: the Perugia General Practitioner Study.

Authors:  Valentina Salvatori; Cecilia Becattini; Stefano Laureti; Gregorio Baglioni; Fabrizio Germini; Piero Grilli; Francesco Guercini; Esmeralda Filippucci; Giancarlo Agnelli
Journal:  Intern Emerg Med       Date:  2015-05-06       Impact factor: 3.397

Review 5.  Cryoablation of atrial fibrillation.

Authors:  Jonathan P Piccini; James P Daubert
Journal:  J Interv Card Electrophysiol       Date:  2011-08-09       Impact factor: 1.900

6.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

Authors:  Bouwe P Krijthe; Anton Kunst; Emelia J Benjamin; Gregory Y H Lip; Oscar H Franco; Albert Hofman; Jacqueline C M Witteman; Bruno H Stricker; Jan Heeringa
Journal:  Eur Heart J       Date:  2013-07-30       Impact factor: 29.983

7.  Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation.

Authors:  Kristoffer Mads Henningsen; Brian Nilsson; Julia S Johansen; Xu Chen; Steen Pehrson; Jesper Hastrup Svendsen
Journal:  Inflamm Res       Date:  2009-12-10       Impact factor: 4.575

8.  Prevalence, clinical correlates and treatment of permanent atrial fibrillation among the elderly: insights from the first prospective population-based study in rural Greece.

Authors:  Ilias Ninios; Harilaos Bogossian; Markus Zarse; Fotini Lazaridou; Kyriakos Dimitriadis; Vlasios Ninios; Bernd Lemke; George Louridas
Journal:  J Thromb Thrombolysis       Date:  2010-07       Impact factor: 2.300

9.  AT1 mutations and risk of atrial fibrillation based on genotypes from 71,000 individuals from the general population.

Authors:  Sarah C W Marott; Børge G Nordestgaard; Gorm B Jensen; Anne Tybjaerg-Hansen; Marianne Benn
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

Review 10.  Status of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.